HST Global, Inc. (HSTC) Research

HST Global, Inc. operates as a biotechnology firm dedicated to integrated health and wellness. The company establishes and acquires a global network of specialized wellness centers, which offer homeopathic and alternative treatments primarily for patients suffering from advanced-stage cancers. Furthermore, HST Global focuses on the development of homeopathic and alternative therapeutic candidates that are either currently undergoing or have successfully completed clinical trials. These potential treatments are designed to address late-stage cancers as well as various other critical, life-threatening conditions. The company's corporate headquarters are situated in Hampton, Virginia.

Market snapshot

Symbol
HSTC
Price
$0.70
Day change
0.00%
Market cap
$29.9M
P/E ratio
-163.82x
52-week range
0.0001-1.05
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Aridis Pharmaceuticals, Inc. (ARDS)
  • Biostax Corp. (BTAX)
  • Evelo Biosciences, Inc. (EVLO)
  • GSRX Industries Inc. (GSRX)
  • Infinity Pharmaceuticals, Inc. (INFIQ)
  • Life Stem Genetics Inc. (LIFS)
  • Oncology Pharma Inc. (ONPH)
  • Scorpius Holdings, Inc. (SCPX)

Recent insider activity

  • Murphy Jason — trade (0 shares) on 2024-04-14
  • Field Michael L — trade (0 shares) on 2024-05-13
  • Howell Ronald R. — trade (0 shares) on 2010-12-31
  • Howell Ronald R. — trade (0 shares) on 2009-12-31
  • Howell Ronald R. — trade (0 shares) on 2008-12-31

Open HST Global, Inc. (HSTC) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.